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A number of administrative tools have been developed to mea-sure comorbidity—or burden of illness—through claims data. Instruments such as the diagnostic cost Group/Hierarchi-
cal condition category (dcG/Hcc),1 the Johns Hopkins Adjusted 
clinical Groups (AcGs),2 and the chronic Illness and disability Pay-
ment System (cdPS),3 were created to measure actuarial risk but have 
been extended to numerous other purposes, such as targeting high-risk 
patients for case management, profiling physician performance, and 
conducting outcomes research.4 most recently, the Affordable care 
Act (AcA) proposes to use individual risk scores to determine or vali-
date average plan risk within health insurance exchanges.5,6 Plan av-
erage risk scores, in turn, will be used to reallocate premiums within 
exchanges so that plans with a disproportionate share of sicker indi-
viduals will be compensated for losses. Thus, the issue of the validity of 
commonly used risk tools is assuming increased importance and exam-
ining potential vulnerabilities is an urgent issue.
In the absence of readily available standardized clinical information, 
administrative data are often the only practical source of information for 
estimating illness burden. Typically tools such as the AcG and cdPS 
calculate a case-mix score by combining diagnostic and/or prescription 
drug codes with demographic variables associated with variation in uti-
lization, such as gender and ge. Some tools use prescription drug codes 
instead of or in addition to diagnostic codes.
Various authors have noted the limitations of these tools.7-9 This ar-
ticle makes the case for another common, unrecognized vulnerability. 
Specifically, the validity of administrative data as a proxy for comorbidity 
requires that beneficiaries have adequate access to healthcare services 
in order to generate a reasonably complete diagnostic profile. As this 
paper will demonstrate, scant or missing diagnosis codes and cost data 
can severely bias case-mix scores, even for very sick populations. Argu-
ably, tools that use pharmacy data may compensate somewhat, because 
many chronically ill individuals use prescriptions even when they do not 
regularly see a provider. However, these tools are limited by the lack of 
specificity in the uses of many drugs. In addition, because many indi-
viduals now obtain prescriptions from $4 generic drug retail programs, 
insurer prescription records can 
no longer be assumed to represent 
reliable records of utilization.10 
We illustrate these vulnerabili-
ties with the AcG by showing 
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Objectives: To demonstrate a threat to validity in 
using claims-based risk tools with chronically ill, 
underinsured populations.  
Study Design: We tracked disease burden of high-
risk pool beneficiaries with potentially disabling 
health conditions receiving enhanced health insur-
ance benefits through a federally funded research 
demonstration. At baseline, beneficiaries paid high 
premiums and cost sharing for risk pool coverage, 
and most met common criteria for underinsur-
ance. Study benefits provided intervention group 
members premium and cost-sharing subsidies and 
additional coverage; control group members paid 
usual premiums and coinsurance and received 
usual benefits. We hypothesized that enhanced 
benefits for the intervention group would increase 
or stabilize health status measures and decrease 
case-mix weights, reflecting stabilized or reduced 
disease burden.  
Methods: The SF-12v2 health survey was used 
to measure health status and the Johns Hopkins 
Adjusted Clinical Groups (ACGs), Version 8.2 with 
DX-PM model and prior cost for a non-elderly 
population, was used to measure disease burden.
Findings: Over a 3-year period, SF-12v2 scores 
showed stable health status for the intervention 
group and significant decline for the control group, 
while ACG case-mix weights, major illnesses, and 
chronic condition counts rose significantly for the 
intervention group but remained stable for the 
control group. Increased resource utilization for 
the intervention group appears to have driven 
increases in ACG measures.  
Conclusions: When high cost-sharing constrains 
access to care, risk tools that rely on medical 
claims may not provide an accurate measure of 
disease burden.
(Am J Manag Care. 2012;18(12):e468-e476)
 In this article
  Take-Away Points / e469
 Published as a Web exclusive
  www.ajmc.com
VOL. 18, NO. 12 n THe AmerIcAN JOUrNAL OF mANAGed cAre n	 e469
Claims-Based Risk estimation
how scores were influenced by a dramatic 
increase in utilization among a group of 




The demonstration to maintain Inde-
pendence and employment (dmIe) was 
a study of disability outcomes sponsored 
by the centers for medicare & medicaid 
Services (cmS) under the Ticket to Work and Work Incen-
tives Improvement Act (TW-WIIA) of 1999 and indepen-
dently conducted by 4 states between 2006 and 2009.11 The 
demonstrations tested the hypothesis that improved access 
to healthcare and personal supports would prevent or delay 
transition to reliance on Social Security disability benefits 
among a population with potentially disabling conditions. 
The intervention was targeted to uninsured or underinsured 
populations whose high healthcare costs may have resulted 
in their delaying or forgoing needed health services. We hy-
pothesized that the intervention would work over time by re-
ducing barriers to care seeking, thus improving health status 
and reducing the burden of illness. This paper describes the 
experience of the Kansas dmIe, which recruited participants 
from the state high-risk insurance pool. The case-mix findings 
reported below pertain to the subset of the study population 
that was continuously enrolled for the first 2 years of the study. 
A more complete description of the full study population and 
outcomes is reported elsewhere.12,13
As with most other state high-risk pools, the Kansas pool 
offers a benefit package modeled on nongroup coverage, 
which typically has less generous benefits and is more expen-
sive than group coverage. At baseline, premiums were 125% 
of standard market rates. deductibles ranged from $500 to 
$7500, with no benefits available prior to meeting the de-
ductible, other than a $250 preventive benefit in some plans. 
Prescription coinsurance was 50%, and medical coinsurance 
was 30% in-network and 50% out-of-network, with out-of-
network charges not accruing toward the annual coinsurance 
maximum. Some plans had a $100,000 annual maximum, and 
all had a lifetime limit of $1 million. The coinsurance cap for 
in-network services was $5000 for single policies and $14,000 
for family plans, with some plans having unlimited 10% coin-
surance thereafter. 
Study Design
The study design was a clinical trial with applicants 
randomly assigned to equal-sized intervention and control 
groups. control group members received high-risk pool ben-
efits as usual, plus cash stipends for participation in surveys 
($1200 paid in progressively increasing installments) and fo-
cus groups ($25 per session).
The intervention consisted of premiums subsidized to a 
flat $152 per month; elimination of all deductibles and co-
insurance; cost-sharing limited to a $3 copay per service and 
charges in excess of reasonable and customary for out-of-net-
work services; and a $1 million lifetime limit for dmIe-paid 
services. The intervention also provided nursing case man-
agement to coordinate care and pre-authorize benefits.
To be eligible, participants had to be enrolled in the state 
high-risk pool at least 6 months prior to recruitment and be 
aged 18 to 60 years, so that no one would turn 65 years during 
the study and attain medicare coverage. They had to experi-
ence 1 or more health conditions that represented a potential 
for disability, as designated by cmS and the state program 
administrators. data collected included claims files, surveys 
including standardized health status assessments and other 
questions, and focus group discussions. This research design 
and evaluation plan was approved by the institutional review 
board affiliated with the authors.
Participant Recruitment
The program began recruiting participants in the fall of 
2005 and offered intervention services from April 2006 
through September 2009. Over this time a total of n = 508 
subjects participated. The present analysis is limited to the 
subset of subjects who were continuously enrolled during the 
first 2 years of the study (n = 317, cohorts 1 and 2). The re-
cruitment process is described in more detail elsewhere.12,13
 Although intervention and control groups were equal 
sized at baseline, large control group attrition resulting from 
dropping high-risk pool coverage created an imbalance in 
group size over time (n = 184 intervention, n = 133 control by 
the end of the second year). comparison of demographic and 
health status data, including interviews that tracked reasons 
for disenrolling and types of replacement coverage, showed 
Take-Away Points
n	 Risk tools based on International Classification of Diseases, Ninth Revision, Clini-
cal Modification codes assume that access to care is sufficient to adequately represent 
health status.
n	 Access barriers may mean that many conditions, even major comorbidities, are not 
coded.
n	 While the Affordable Care Act (ACA) may bring coverage to millions of previously 
uninsured individuals, many will still face high cost sharing. In addition, they may have 
higher than average comorbidity because of lower socioeconomic status.
n	 Since the ACA proposes to use individual risk scores in adjusting risk across exchan-
ges, and because claims-based risk tools are widely used for other purposes, the poten-
tial bias associated with underutilization should be recognized. 
e470 n www.ajmc.com n december 2012
n methods n
n Table 1. DMIE Participant Demographics by Group and Total at Baseline
Characteristic Intervention Control Total
N 184 133 317
Female 48.9% 50.4% 49.5%
Age, y, mean (SD) 51.3 (8.2) 51.8 (8.7) 51.5 (8.4)
  18-39 7.1% 7.5% 7.3%
  40-49 26.1% 25.6% 25.9%
  50-59 55.4% 49.6% 53.0%
  60-61a 11.4% 17.3% 13.9%
Educational attainment
  More than 4-year college degree 19.0% 21.1% 19.9%
  Some college or 4-year degree 59.8% 59.4% 59.6%
  High school diploma or less 21.2% 19.5% 20.5%
Marital status
  Married 55.7% 58.6% 57.0%
  Single 22.4% 18.0% 20.6%
  Divorced 19.7% 19.5% 19.6%
  Widowed or separated 2.2% 3.0% 2.5%
Homeowner 80.9% 88.7% 84.2%
Own income, $, mean (SD)b 47,698 (58,716) 53,947 (73,882) 50,339 (65,514)
  Median, $ 30,000 33,000 30,000
  Range 350,000 600,000 600,000
Household annual income, $, (SD)b 70,790 (72,518) 72,069 (78,328) 71,333 (74,918)
  Median 50,000 46,500 50,000
  Range 600,000 500,000 600,000
Household income as % of federal poverty levelsb
  <133% 12.5% 10.0% 11.4%
  133%-199% 9.7% 10.0% 9.8%
  200%-299% 14.2% 13.1% 13.7%
  300%-399% 21.6% 23.1% 22.2%
  >400% 42.0% 43.8% 42.8%
Plan deductible
  $500 2.2% 3.0% 2.5%
  $1000 19.6% 15.8% 18.0%
  $1500 21.7% 24.1% 22.7%
  $2500 10.3% 10.5% 10.4%
  $5000 27.2% 29.3% 28.1%
  $7500 19.0% 17.3% 18.3%
Premium, $, mean (range) $456 ($822) $465 ($657) $460 ($822)
Held medical debtc 19.6% 26.3% 22.4%
DMIE indicates Demonstration to Maintain Independence and Employment; SD, standard deviation. 
All between-group differences are statistically non-significant. 
aAlthough the eligibility cap was set at 60 years of age, 2 individuals turned 61 years between enrollment and the beginning of the intervention.  
bFour individuals (3.5%) refused to report income at baseline. 
cQuestion was asked approximately 8 months following baseline.
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that those who disenrolled did not differ significantly from 
those who remained. most disenrollees obtained group cover-
age through their own or a spouse’s employment, where there 
was no underwriting for pre-existing conditions. The reason 
cited for leaving high-risk pool coverage was almost exclu-
sively the unaffordability of coverage. 
Sample Baseline Characteristics
Study participants were demographically similar to the 
overall high-risk pool population, except that they were on 
average slightly younger, reflecting the study’s eligibility cap. 
We found no statistically significant between-group differ-
ences in demographic variables or distribution of comorbidi-
ties (tables 1, 2). most participants were aged 50 to 60 years, 
married, well-educated, and owned homes. mean incomes 
were approximately $50,000 for individuals and $71,000 for 
families, with median individual incomes of $30,000 and 
family incomes of $50,000; 57% were below 400% of poverty 
when family size was included and 21% had incomes below 
200% of federal poverty level. Occupations included home-
based service or manufacturing enterprises, farming, profes-
sional services, and small business ownership. About 70% of 
participants earned at least some income from self-employ-
ment, explaining this population’s lack of access to group 
health insurance. 
baseline claims and self-reported diagnoses showed that 
participants experienced numerous comorbid conditions 
(Table 2). musculoskeletal pain, cardiovascular conditions, 
and diabetes were among the most common; 19% had can-
cer, either active or by history. Forty-five percent reported at 
least 1 activity of daily living (AdL) limitation and 46% at 
least 1 instrumental activity of daily living (IAdL) limitation, 
most commonly those requiring physical strength and mobil-
ity. based on self-reported height and weight, 75% were over-
weight to obese (body mass index [bmI] >25), including 32% 
obese (bmI >30-40) and 11% morbidly obese (bmI >40). 
Baseline Health Cost Burden 
baseline claims showed high cost burden. Premiums aver-
aged $460 per month, but ranged from $189 to $1011. Premi-
ums for those aged 50 to 59 years (53% of the sample) ranged 
from $264 per month for a $7500 deductible plan to $878 per 
month for a $500 deductible plan. Only 3% of the sample 
enrolled in the $500 deductible plan, while almost one-half 
(46%) enrolled in $5000 or $7500 deductible plans. median 
and mean out-of-pocket expenses were $1639 and $2472, re-
spectively, compared with $960 and $575 nationally for non-
elderly individuals covered by individual and group plans.14 
because of high deductibles and cost-sharing, participants, 
on average, paid 61% of allowed costs. Only 58% received 
reimbursement for more than one-half of allowed costs, and 
one-third received no reimbursement because they did not 
meet their deductible. Using a common definition of under-
insurance—a deductible exceeding 5% or medical expenses 
exceeding 10% of family income; or if low-income, medical 
expenses exceeding 5% of family income—82% of the sample 
was underinsured.15 because our data do not include expenses 
for other family members, the underinsurance rate is likely 
even higher.
In focus group discussions and during survey interviews, 
participants described how medical spending caused them 
considerable financial hardship and emotional stress. Twenty-
two percent reported medical debt, with 25% owing $5000 or 
more and 6% $20,000 or more. They told of delaying or forgo-
ing preventive services, diagnostic testing, elective surgeries, 
and medical equipment and employing strategies to stretch 
medication supplies, such as skipping pills, selectively not fill-
ing prescriptions, and continuing to use old medications after 
new ones had been prescribed.13 They also reported enrolling 
in plans with high deductibles because these were the only 
ones for which they could afford the premiums.16
Health Status Measures. The primary instrument for 
measuring health status was the SF-12v2, a scale derived from 
the SF-36.17 We also administered the World Health Orga-
nization Quality of Life brief form (WHOQOL-breF), the 
World Health Organization Health and Work Performance 
Questionnaires (HPQs), standardized AdL-IAdL measures,18 
and asked for self-reported diagnoses and health conditions. 
All instruments were administered by telephone at baseline 
and at 8-month intervals over the 41-month study period (5 
rounds). SF-12v2 data are reported below for the first 4 rounds 
(baseline plus 3) corresponding with the first 2 years of the 
study. claims data for case mix analysis are summarized for the 
corresponding 2-year period.
To measure comorbidity burden (case mix), we used the 
AcG, Version 8.2 with dX-Pm model and prior cost for a 
non-elderly population.19 We did not include prescription 
data because a preliminary analysis indicated it did not sig-
nificantly affect outcomes for this study population. The 
AcG maps each beneficiary’s age, gender, and diagnostic 
codes to a single actuarial cell, or AcG, representing their 
estimated resource use. AcG reference unscaled concurrent 
weights, or case-mix weights, are ratios comparing estimated 
resource use for a given AcG with the average resource use 
of a nationally representative sample of insured individuals. 
The average case-mix weight for the national population is 
set at 1. Thus, someone with a case-mix weight of 2 has an 
estimated resource use twice the national average. Although 
AcG case-mix weights are measures of estimated resource 
use, they are also proxy measures of disease burden. Gener-
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Maximum Combined Claims  
and Self-Report
Intervention Control Intervention Control Intervention Control Total
ICD-9-CM Category (Codes)a
  Immune (042, 279) 2.2 1.5 2.2 1.5 2.7 1.5 2.2
  Cancers (140-165, 170-172, 174-177,  
  179-208, 230-235)
14.1 12.8 15.2 15.0 19.6 17.3 18.6
  Diabetes/endocrine (250, 277) 28.3 23.3 27.7 22.6 30.4 27.1 29.0
  Blood (282-289) 6.5 6.8 2.2 3.0 7.6 7.5 7.6
  Psychiatric (294-301, 310-311) 14.1 21.1 33.2 33.8 34.2 39.1 36.3
  Neurological (331-337, 340-345,  
  350-359)
11.4 12.8 12.5 9.8 17.4 17.3 17.4
  Stroke (430-438) 2.7 2.3 1.1 1.5 2.7 3.0 2.8
  Sensory (360-365, 369, 386-388) 7.1 6.8 3.8 2.3 10.3 8.3 9.5
  Cardiovascular (393-398, 410-417,  
  420-429, 440-448)
22.3 27.8 23.4 30.1 29.3 36.8 32.5
  Respiratory (491-496, 500-504) 8.7 6.8 18.5 20.3 20.1 22.6 21.1
  Gastrointestinal (555-556, 570-573) 3.3 6.8 7.1 9.8 8.2 12.8 10.1
  Renal (580-589) 1.6 1.5 1.6 2.3 3.3 3.0 3.2
  Musculoskeletal (710-725, 731-732, 
  737, 741)
35.3 37.6 36.4 36.8 52.7 51.9 52.4
Limited ADLa
  Any ADL — — 46.7 42.1 — — 44.8
  Walking — — 39.7 35.3 — — 37.9
  Transferring from bed and chair — — 20.7 26.3 — — 23.0
  Getting outside — — 14.8 13.6 — — 14.3
  Dressing — — 12.5 9.8 — — 11.4
  Bathing — — 12.5 7.5 — — 10.4
  Toileting — — 9.8 6.1 — — 8.3
  Eating — — 6.0 4.5 — — 5.4
Limited IADLa
  Any IADL — — 47.8 42.9 — — 45.7
  Heavy housework — — 43.7 36.4 — — 40.6
  Shopping — — 18.5 14.4 — — 16.8
  Travel outside walking distance — — 15.8 8.3 — — 12.6
  Light housework — — 9.2 8.3 — — 8.8
  Money management — — 7.1 2.3 — — 5.1
  Rx management — — 6.0 3.0 — — 4.7
  Meal preparation — — 3.8 4.5 — — 4.1
  Telephone — — 2.2 0 — — 1.3
BMIb
  Total overweight or obese — — 74.3 75.9 — — 75.0
  Underweight (<18.5) — — 2.2 1.5 — — 1.9
  Normal weight (18.5-25) — — 23.5 22.6 — — 23.1
  Overweight (25-30) — — 30.1 33.8 — — 31.6
  Obese (30-40) — — 32.2 31.6 — — 32.0
  Morbidly obese (40+) — — 12.0 10.5 — — 11.4
ADL indicates activities of daily living; BMI, body mass index; IADL, instrumental activities of daily living; ICD-9-CM, International Classification of Dis-
eases, Ninth Revision, Clinical Modification; Rx, script. 
All between-group differences are statistically non-significant. N = 317.  
aDoes not total to 100% because of comorbidities wherein individuals may report more than 1 of these categories.  
bCalculated from self-reported height and weight.
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ally, weights greater than 1.0 
indicate a population is sick-
er than the national average, 
and weights of less than 1.0 
indicate it is healthier.19
AcG software also pro-
duces other measures of 
disease burden, including Ag-
gregated diagnostic Groups 
(AdGs), expanded diagnos-
tic clusters (edcs), counts 
of major edcs (chronic con-
dition counts), and resource utilization bands (rUbs). recent 
versions have also included a predictive model algorithm for 
forecasting cost.
Our hypothesis was that SF-12v2 PcS and mcS scores 
would stabilize or decrease more slowly for the intervention 
than the control group, while AcG case-mix weights would 
steadily decrease for the intervention group, reflecting re-
duced disease burden and improved health.
FINDINGS
The data presented here were collected as part of a 
randomized controlled study and reflect the subsample 
continuously enrolled for the first 2 years of the study. For 
the entire study population, over 32 months, interven-
tion group SF-12v2 PcS scores remained relatively stable 
but control group scores significantly declined.12 For this 
subsample, the same trend was evident, even though the 
between-group difference did not approach statistical sig-
nificance by the end of year 2. However, the within-group 
difference showed that the control group was declining at 
a significantly greater rate (P = .01 control group, P = .58 
intervention, repeated measures analysis of variance [ANO-
VA], table 3). PcS scores did not differ significantly by 
economic status, as measured by family income as a percent 
of federal poverty level. 
Previous research on the medical Outcomes Study, from 
which the SF-12v2 is derived, found that the average age-
related decline for healthy populations 45 to 64 years of 
age is 0.4 points per year.20 As Table 3 shows, PcS scores 
for the intervention group fluctuated plus or minus 1 point 
while control group scores declined by 2.45 points over a 
24-month period. Survey data also showed different self-re-
ported health status. At study end, 34% of the intervention 
group indicated their health had improved compared with 
21% of the control group; conversely, only 19% of the in-
tervention group reported worsening health compared with 
31% of controls; approximately equal proportions (46% in-
tervention vs 48% control) said their health had remained 
the same (P = .01, Pearson χ2).
 In contrast, the trend for AcG case mix moved inversely 
(table 4). At baseline, the groups did not differ significantly 
on any AcG measure. both had case-mix weights approxi-
mately 3 times the national average (2.97 intervention vs 
3.59 control). both groups had 1.1 major illnesses (AdG) and 
2.6 chronic conditions. Average costs for the control group 
were slightly, but not significantly, higher ($11,124 vs $8563).
by the end of year 1, intervention group case-mix weights 
had increased to 4.2 and by year 2 to 4.98 (P = .00, repeated 
measures ANOVA). Over the 2 years the percent of partici-
pants with high to very high resource use also increased from 
approximately one-third (31%) to one-half (52%) and aver-
age cost almost doubled, from $8563 to $16,725 (P = .00). 
On the other hand, there were no significant changes in any 
AcG metric within the control group. 
As table 5 demonstrates, a large shift to higher acuity for 
intervention group members occurred in years 1 and 2. be-
cause AcGs are mutually exclusive actuarial cells, the pro-
portion of beneficiaries with higher-acuity AcGs displaced 
those with lower-acuity AcGs. The proportions of interven-
tion members with 10 or more diagnosis clusters grew 72% 
the first year and almost doubled by the second year, and the 
proportion with 6 to 9 diagnostic clusters grew 62% during 
the first year.
DISCUSSION
The comparative spike in case mix rates for the group 
that gained greater access to services illustrates an important 
limitation of risk tools based on administrative data. Greater 
utilization of care increases the chance that more conditions 
will be diagnosed, even those that are only suspected. more 
International Classification of Diseases, Ninth Revision, Clinical 
Modification (ICD-9-CM) codes drive up case mix, regard-
less of whether health status has changed. For our subjects, 
SF-12v2 PcS scores suggest that, over the first 24 months, 
n Table 3. Within-Group Changes in SF-12v2 PCS Scoresa Over a 2-Year Period
Baseline 8 Mos 16 Mos 24 Mos P
Intervention
  Means 42.9 42.8 42.4 42.0 .50
  Confidence intervals 41.1-44.7 41.1-44.6 40.7-44.1 40.2-43.9
Control
  Means 44.4 43.0 43.1 41.9 .006
  Confidence intervals 42.4-46.3 41.0-45.0 41.1-45.1 39.9-44.0
aThe national norm for SF-12v2 PCS scores is 50.  
P = repeated measures analysis of variance.
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the intervention group actually experienced better health sta-
tus than the control group, or, at the very least, certainly no 
worse. case-mix and other AcG scores, on the other hand, 
suggest the intervention group experienced a dramatic wors-
ening of health status. The same measures for controls, which 
differed only in the level of services received, showed no sig-
nificant change. Other studies similarly have found risk scores 
more dependent on utilization patterns than comorbidity. For 
instance, Song et al found that when medicare beneficiaries 
from low-intensity practice regions moved to higher practice-
intensity regions, their Hcc risk scores increased compara-
tively more than those who moved to lower practice-intensity 
regions.21 Welch et al found that case-mix scores did not pre-
dict mortality. In fact, the case fatality rate among medicare 
beneficiaries moved inversely with the mean number of se-
rious conditions diagnosed in 306 hospital referral regions; 
paradoxically, the greater the number of serious conditions 
diagnosed, the lower the fatality rate.22
Several potential explanations exist for the case mix in-
crease among intervention subjects. One possibility is that 
the latter scores represent a more valid estimate of comor-
bidity than at baseline because both groups had previously 
been underserved. This interpretation is supported by evi-
dence from a variety of qualitative and quantitative sources. 
First, at least 82% met criteria to be considered underinsured 
relative to their ability to pay for care. Participants in 6 fo-
cus groups (n = 42) conducted during the first 2 years of our 
study reported forgoing or deferring care for complex and 
potentially serious conditions, such as kidney disease and 
gastrointestinal bleeding, and employing numerous strat-
egies to minimize cost, such as saving up procedures until 
they had met deductibles and rationing medications.16 Once 
the dmIe program benefits removed the cost barriers, they 
reported that they were able to afford needed services. We 
examined the records of individuals with large changes in 
AcG weights and found baseline self-reported conditions, 
such as diabetes and a cancer history, for which they had no 
claims during the baseline year but which were treated after 
the intervention began. 
The time-limited nature of the intervention may have 
also encouraged those individuals with pent-up need to con-
sume high levels of service while the dmIe benefit was in 
place. Although all types of service consumption increased, 
we saw notable spikes in elective surgeries, such as joint re-
placements, expensive screening and diagnostic testing, and 
services not included or for which coverage was very limited 
under the basic state high-risk pool benefit. The latter in-
clude prescription coverage with cost sharing of 50% after 
deductible that decreased to a flat $3 per drug copay under 
the dmIe, a major benefit for individuals heavily dependent 
on high-cost prescriptions for conditions such as cancer and 
autoimmune diseases.
n Table 4. Within-Group Changes in ACG Case-Mix and Other Comorbidity Measures Over a 2-Year Period
Intervention Control
Measure Baseline Year 1 Year 2 P Baseline Year 1 Year 2 P
Unscaled concurrent weight 
(case mix)
  Means 2.97 4.20 4.98 .00 3.59 3.10 3.07 .48
  Confidence intervals 2.41-3.53 3.56-4.84 4.15-5.81 2.62-4.57 2.28-3.92 2.28-3.86
Major ADGs
  Means 1.11 1.44 1.51 .00 1.14 1.11 1.05 .70
  Confidence intervals 0.96-1.27 1.30-1.59 1.35-1.68 0.94-1.33 0.92-1.29 0.88-1.23
Chronic condition count
  Means 2.56 3.22 3.39 .00 2.61 2.44 2.57 .56
  Confidence intervals 2.27-2.85 2.91-3.54 3.03-3.75 2.25-2.97 2.05-2.82 2.23-2.92
Average cost
  Means $8563 $13,361 $16,725 .00 $11,124 $10,431 $9942 .92
  Confidence intervals 6376-10,750 10,638-16,084 13,013-20,438 7276-14,973 4396-16,467 6826-13,057
Percent with high to very high 
resource use
  Means 31.0 45.7 52.2 .00 30.8 25.6 30.1 .45
  Confidence intervals 24.2-37.7 38.4-52.9 44.9-59.5 22.9-38.8 18.1-33.1 22.2-38.0
ADG indicates adjusted diagnostic groups or diagnostic group.  
P = repeated measures analysis of variance.
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In addition, all intervention group members received tele-
phonic case management from registered nurses, who assisted 
subjects in identifying unmet needs and provided prior ap-
proval of insurance coverage. Although this surveillance was 
intended to help subjects optimize their health status while 
preventing wasteful utilization, it also inevitably raised aware-
ness of unmet needs and stimulated a demand for services. 
Physicians who became aware of the availability of increased 
coverage also may have made more recommendations for in-
terventions during this time-limited benefit period. 
because of this spike in utilization, some of which repre-
sented pent-up demand, the resulting case-mix scores may be 
inflated. However, many of the conditions for which partici-
pants sought treatment are chronic and represent continued 
clinical and actuarial risk, whether or not they continue to 
be incorporated into risk scores. This temporal aspect of risk 
adjustment highlights another limitation: case-mix scores 
normally encompass only 1 year of data; pre-existing con-
ditions that have not been treated during the past year will 
not be detected, and underlying comorbidity may be vastly 
underestimated.
Study Limitations
The small sample size and high comorbidity risk of this 
study population, consisting of underinsured individuals with 
intensive need for healthcare services, limits the generaliz-
ability to large health plans with more generous health ben-
efits and healthier, or more typically representative, health 
status. In addition, this study was conducted in only 1 small 
state; however, similar case mix increases were observed in 
the Texas dmIe, which used the AcG with a previously un-
insured group of 1400 individuals whose initial health status 
was similar to those in the Kansas dmIe study.23 The findings 
seem most relevant to populations with high unmet health-
care need who suddenly gain access to relatively comprehen-
sive healthcare benefits.
CONCLUSIONS
The AcA proposes to use risk adjustment as a permanent 
mechanism for protecting insurance plans against adverse 
selection. The federal government will provide insurance 
exchanges with a risk-adjustment tool, such as the Hcc, 
or allow a comparable substitute. but all of these tools share 
important vulnerabilities. Although intended to shield plans 
against adverse selection, these tools may inadvertently re-
ward the inefficient at the expense of the efficient. At worst, 
they could encourage insurance industry “gaming” in order to 
maximize revenues and shareholder profits.24
claims-based tools may be particularly inaccurate when 
beneficiaries are chronically ill and underinsured. When 
many Americans gain coverage for the first time under the 
AcA, these factors may be an important issue in understand-
ing risk scores. many uninsured Americans are of lower so-
cioeconomic status and in poor health.25 Those who enroll 
in exchanges will still have cost-sharing barriers, particularly 
if they are above the 200% federal poverty threshold, where 
coinsurance is no longer subsidized. If they do not attain ad-
equate access to services, their comorbidity risk may be under-
estimated by case mix–based risk scores. At this writing, how 
n Table 5. Within Group Percentage Changes in ACG Acuity Over a 2-Year Period
Intervention Control
Highest Level of Acuity 
(ACG Actuarial Cell)
Baseline Year 1 Year 2 Baseline Year 1 Year 2
<10 ADGs (5010-5070) 16.3 28.0 32.2 12.0 10.5 15.0
6-9 ADGs (4510-4940) 25.5 41.2 40.4 31.6 25.6 29.3
4-5 ADGs (4210-4430) 20.7 14.8 12.0 18.8 19.5 10.5
2-3 ADGs (3800-4100 16.3 10.4 8.7 14.3 19.5 18.0
Acute (100-400, 1800-3700) 10.3 2.7 4.9 8.3 10.5 12.8
Chronic (800-900, 1200) 3.3 — 0.5 3.8 4.5 0.8
Psychiatric (1300-1500) 0.5 1.6 0.5 1.5 2.3 3.0
Preventive (1600) 0.5 — — 1.5 2.3 1.5
Likely to recur (500-600) 1.1 — — — 0.8 —
Eye and dental (1100) — 0.5 — — — 0.8
Nonusers (5100-5200) 5.4 0.5 0.5 8.3 4.5 8.3
Total 100.0 100.0 100.0 100.0 100.0 100.0
ACG indicates adjusted clinical group; ADG, aggregated diagnostic group.
e476 n www.ajmc.com n december 2012
n methods n
the federal government will make use of individual risk scores 
is unsettled, and the AcA includes other interim financial 
safeguards in the form of reinsurance and risk corridors. How-
ever, policy makers, as well as others who contemplate the use 
of these tools for measuring comorbidity, need to be aware of 
this potential threat to their validity.
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